On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital Management, Surveyor Capital, venBio Partners, Vivo Capital, featuring lead investors Logos Capital.

About the company: Attralus is located at United States, North America.
“Improving diagnosis & treatment in systemic amyloid diseases with cutting-edge diagnostic imaging and therapeutic medicine”

Company website: http://www.attralus.com